Pancreastatin plasma levels in patients with primary hyperparathyroidism

World Journal of Surgery

Volumn 24, Issue 12, 2000, Pages 1579-1583

  Bergenfelz, Anders ^a   Luts, Lena ^b   Børglum Jensen, Tine ^c   Sundler, Frank ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHROMOGRANIN A; INSULIN; PANCREASTATIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MALE; ORGAN WEIGHT; PARATHYROID ADENOMA; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; STOMACH ACID; TUMOR VOLUME;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC HORMONES; PARATHYROID NEOPLASMS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 0034524701     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010281     Document Type: Article

References (44)

1. Chromogranin: Widespread immunoreactivity in polypeptide hormone producing tissue and in serum
2. Selective localization of the parathyroid secretory protein I/adrenal medulla chromogranin A protein family in a wide variety of endocrine cells of the rat
3. Panneuronal expression of chromogranin A in rat nervous system
4. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues
5. Parathyroid secretion: Discovery of a major calcium-dependent protein
6. Cosecretion of secretory protein I and parathyroid hormone by dispersed bovine parathyroid cells
7. Is chromogranin a prohormone?
8. Chromogranin A and pancreastatin
9. Secretion from chromaffin cells is controlled by chromogranin A derived peptides
10. Pancreastatin a novel pancreatic peptide inhibits insulin secretion
11. Chromogranin A (201-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors
12. Different secretory actions of pancreastatin in bovine and human parathyroid cells
13. Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleid acids in parathyroid cells in culture
14. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture
15. Pancreastatin and islet hormone release
16. Effects of pancreastatin on insulin and glucagon and somatostatin secretion by the perfused rat pancreas
17. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice
18. 2+-dependent mechanism
19. Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo
20. Increased plasma pancreastatin-like immunoreactivity in nonobese patients with essential hypertension
21. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension
22. Bioactivity of synthetic human pancreastatin on pancreas
23. Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat
24. Pancreastatin: A novel peptide inhibitor of parietal cell signal transduction
25. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue
26. Metabolic complication of primary hyperparathyroidism
27. Mortality after surgery for primary hyperparathyroidism: A follow-up of 441 patients operated on from 1956-1979
28. Premature death in patients operated on for primary hyperparathyroidism
29. The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism
30. Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism
31. Characterization of immunoreactive pancreastatin in porcine tissues
32. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism
33. Immunocytochemical localisation of pancreastatin and chromogranin A in porcine neuroendocrine tissues
34. Pancreastatin: Molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues
35. Immunohistochemical localization of chromostatin and pancreastatin, chromogranin A-derived bioactive peptides, in normal and neoplastic neurendocrine tissues
36. Evidence for pancreastatin synthesis in pig parathyroid
37. Pancreastatin and bovine parathyroid cell secretion
38. Parathyroid fuction and histology in patients with parathyroid adenoma: Correlation of clinical and morphological findings
39. Plasma chromogranin A in primary hyperparathyroidism
40. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones
41. Recovery of parathyroid hormone secretion after parathyroid adenomectomy
42. Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy
43. Functional recovery of the parathyroid glands after surgery for primary hyperparathyroidism
44. Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism